Brewers face a new problem as more people take GLP-1 drugs, with Fox59 looking at how the shift is hitting beer demand.
Recap by typeshit. Post by Facebook on Facebook.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
LLY reached a fresh record while many tech stocks keep swinging, and the post weighs whether investors should take some profits.
KKM says it has seized 759 units of GLP-1 receptor agonist products worth RM405,170 since 2025 in its crackdown on unlicensed sellers.
Loading…